Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Saphmox 500 - Philippines FDA Drug Approval Details

Approvals/Philippines FDA/Saphmox 500

Approved

STANDARD

Saphmox 500

Sunlovis Pharmaceuticals LLP🇵🇭 Food and Drug Administration - Philippines

Approval Date: Jul 14, 2025
Approval ID: 0a09bf4ca6b2bccb
Company: Sunlovis Pharmaceuticals LLP
Type: Standard

Approval Details

Approval Id: 0a09bf4ca6b2bccb
Drug Approval Philippines Name: Saphmox 500
Product Name: Saphmox 500
Registration Number: DRP-8388
Brand Name: Saphmox 500
Generic Name: Amoxicillin (as Trihydrate)
Dosage Form: Capsule
Dosage Strength: 500mg
Manufacturer: Sunlovis Pharmaceuticals LLP
Trader: Sapphire Lifesciences Pvt. Ltd.
Importer: Nelpa Lifesciences, Inc.
Distributor: Nelpa Lifesciences, Inc.
Issuance Date: 27 December 2022
Expiry Date: 04 August 2026
Pharmacologic Category: Antibacterial (Penicillin)
Classification: Prescription Drug (RX)

Active Ingredients

Approved

Quick Info

Agency

Philippines FDA

Country

🇵🇭

Approval Date

Jul 14, 2025

Approval ID

0a09bf4ca6b2bccb

Type

Standard

Back to Philippines FDA Approvals